Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Cancers
|
January 11, 2025
Cost-Effectiveness of PARP Inhibitors for Patients with BRCA1/2-Positive Metastatic Castration-Resistant Prostate Cancer-The Canadian Perspective
Ivan Yanev, Armen G Aprikian, Brendan L Raizenne, et al.
European Urology Oncology
|
September 4, 2025
Clinical Comparison of Decipher 1.0 and 1.1 for Localized Prostate Cancer: Results in Prostatectomy and Active Surveillance Patients
Brendan L Raizenne, Kevin Shee, Janet E Cowan, et al.
World Journal of Urology
|
February 2, 2022
Real-world data comparing minimally invasive surgeries for benign prostatic hyperplasia
Brendan L Raizenne, Xinyan Zheng, Jialin Mao, et al.
World Journal of Urology
|
August 30, 2022
Functional and surgical outcomes of Aquablation in elderly men
Brendan L Raizenne, David Bouhadana, Kevin C Zorn, et al.
The Journal of Urology
|
June 9, 2026
Reply by Authors
Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky, et al.
The Journal of Urology
|
March 17, 2026
Preoperative ctDNA Predicts Upstaging and Recurrence in High-Risk Non-Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy
Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky, et al.
World Journal of Urology
|
December 3, 2022
Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study
Brendan L Raizenne, Xinyan Zheng, Kussil Oumedjbeur, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 11, 2024
Kidney stone disease Practice patterns among urologists in Canada
Anis Assad, Mahmoud Moustafa, Brendan L Raizenne, et al.
European Urology Oncology
|
January 31, 2026
A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer
Kevin Shee, William A Pace, Jonathan J Song, et al.
Clinical Genitourinary Cancer
|
March 21, 2026
Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder Cancer
Brendan L Raizenne, Vadim S Koshkin, Alec Zhu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Cancers
|
January 11, 2025
Cost-Effectiveness of PARP Inhibitors for Patients with BRCA1/2-Positive Metastatic Castration-Resistant Prostate Cancer-The Canadian Perspective
Ivan Yanev, Armen G Aprikian, Brendan L Raizenne, et al.
European Urology Oncology
|
September 4, 2025
Clinical Comparison of Decipher 1.0 and 1.1 for Localized Prostate Cancer: Results in Prostatectomy and Active Surveillance Patients
Brendan L Raizenne, Kevin Shee, Janet E Cowan, et al.
World Journal of Urology
|
February 2, 2022
Real-world data comparing minimally invasive surgeries for benign prostatic hyperplasia
Brendan L Raizenne, Xinyan Zheng, Jialin Mao, et al.
World Journal of Urology
|
August 30, 2022
Functional and surgical outcomes of Aquablation in elderly men
Brendan L Raizenne, David Bouhadana, Kevin C Zorn, et al.
The Journal of Urology
|
June 9, 2026
Reply by Authors
Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky, et al.
The Journal of Urology
|
March 17, 2026
Preoperative ctDNA Predicts Upstaging and Recurrence in High-Risk Non-Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy
Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky, et al.
World Journal of Urology
|
December 3, 2022
Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study
Brendan L Raizenne, Xinyan Zheng, Kussil Oumedjbeur, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 11, 2024
Kidney stone disease Practice patterns among urologists in Canada
Anis Assad, Mahmoud Moustafa, Brendan L Raizenne, et al.
European Urology Oncology
|
January 31, 2026
A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer
Kevin Shee, William A Pace, Jonathan J Song, et al.
Clinical Genitourinary Cancer
|
March 21, 2026
Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder Cancer
Brendan L Raizenne, Vadim S Koshkin, Alec Zhu, et al.
Page
of 2